BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 19369464)

  • 1. HLA-G expression in the skin of patients with systemic sclerosis.
    Wastowski IJ; Sampaio-Barros PD; Amstalden EM; Palomino GM; Marques-Neto JF; Crispim JC; Biral AC; Rassi DM; Carosella ED; Moreau P; Donadi EA
    J Rheumatol; 2009 Jun; 36(6):1230-4. PubMed ID: 19369464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Vdelta1+ T cells are activated and accumulate in the skin of systemic sclerosis patients.
    Giacomelli R; Matucci-Cerinic M; Cipriani P; Ghersetich I; Lattanzio R; Pavan A; Pignone A; Cagnoni ML; Lotti T; Tonietti G
    Arthritis Rheum; 1998 Feb; 41(2):327-34. PubMed ID: 9485091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.
    Manetti M; Guiducci S; Romano E; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2012 Jun; 71(6):1064-72. PubMed ID: 22258486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of endothelin-1 and its binding sites in scleroderma skin.
    Vancheeswaran R; Azam A; Black C; Dashwood MR
    J Rheumatol; 1994 Jul; 21(7):1268-76. PubMed ID: 7525957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of basic fibroblast growth factor in skin of patients with systemic sclerosis.
    Lawrence A; Khanna D; Misra R; Aggarwal A
    Dermatol Online J; 2006 Jan; 12(1):2. PubMed ID: 16638370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study.
    Iannone F; Matucci-Cerinic M; Falappone PC; Guiducci S; Cinelli M; Distler O; Lapadula G
    J Rheumatol; 2005 Oct; 32(10):1893-8. PubMed ID: 16206343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum pentraxin 3 in patients with systemic sclerosis.
    Iwata Y; Yoshizaki A; Ogawa F; Komura K; Hara T; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Rheumatol; 2009 May; 36(5):976-83. PubMed ID: 19273457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement.
    Del Rosso A; Distler O; Milia AF; Emanueli C; Ibba-Manneschi L; Guiducci S; Conforti ML; Generini S; Pignone A; Gay S; Madeddu P; Matucci-Cerinic M
    Ann Rheum Dis; 2005 Mar; 64(3):382-7. PubMed ID: 15708892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of activated complement complex C5b-9 and complement receptor C5a in skin biopsies of patients with systemic sclerosis (scleroderma).
    Sprott H; Müller-Ladner U; Distler O; Gay RE; Barnum SR; Landthaler M; Schölmerich J; Lang B; Gay S
    J Rheumatol; 2000 Feb; 27(2):402-4. PubMed ID: 10685805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis.
    Kissin EY; Merkel PA; Lafyatis R
    Arthritis Rheum; 2006 Nov; 54(11):3655-60. PubMed ID: 17075814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum CXCL16 concentrations correlate with the extent of skin sclerosis in patients with systemic sclerosis.
    Yanaba K; Muroi E; Yoshizaki A; Hara T; Ogawa F; Shimizu K; Yozaki M; Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Rheumatol; 2009 Sep; 36(9):1917-23. PubMed ID: 19605674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased lymphatic vessel counts in patients with systemic sclerosis: association with fingertip ulcers.
    Akhmetshina A; Beer J; Zwerina K; Englbrecht M; Palumbo K; Dees C; Reich N; Zwerina J; Szucs G; Gusinde J; Nevskaya T; Distler O; Kerjaschki D; Schett G; Distler JH
    Arthritis Rheum; 2010 May; 62(5):1513-22. PubMed ID: 20155824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of human leukocyte antigen-G in systemic lupus erythematosus.
    Rosado S; Perez-Chacon G; Mellor-Pita S; Sanchez-Vegazo I; Bellas-Menendez C; Citores MJ; Losada-Fernandez I; Martin-Donaire T; Rebolleda N; Perez-Aciego P
    Hum Immunol; 2008 Jan; 69(1):9-15. PubMed ID: 18295670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of osteonectin and matrix Gla protein in scleroderma patients with and without calcinosis.
    Davies CA; Jeziorska M; Freemont AJ; Herrick AL
    Rheumatology (Oxford); 2006 Nov; 45(11):1349-55. PubMed ID: 17050587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of HLA class II antigens on skin fibroblasts in scleroderma.
    Branchet MC; Boisnic S; Blétry O; Robert L; Charron D; Francès C
    Br J Dermatol; 1992 May; 126(5):431-5. PubMed ID: 1610682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of fetal microchimeric cells in clinically affected and unaffected skin of patients with systemic sclerosis.
    Sawaya HH; Jimenez SA; Artlett CM
    Rheumatology (Oxford); 2004 Aug; 43(8):965-8. PubMed ID: 15199216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis.
    Manetti M; Liakouli V; Fatini C; Cipriani P; Bonino C; Vettori S; Guiducci S; Montecucco C; Abbate R; Valentini G; Matucci-Cerinic M; Giacomelli R; Ibba-Manneschi L
    Ann Rheum Dis; 2009 Mar; 68(3):408-11. PubMed ID: 18930992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-p53 autoantibody in systemic sclerosis: association with limited cutaneous systemic sclerosis.
    Hara T; Ogawa F; Muroi E; Komura K; Takenaka M; Hasegawa M; Fujimoto M; Sato S
    J Rheumatol; 2008 Mar; 35(3):451-7. PubMed ID: 18203319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum interleukin 23 in patients with systemic sclerosis.
    Komura K; Fujimoto M; Hasegawa M; Ogawa F; Hara T; Muroi E; Takehara K; Sato S
    J Rheumatol; 2008 Jan; 35(1):120-5. PubMed ID: 18085738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of 5-lipoxygenase overexpression in the skin of patients with systemic sclerosis: a newly identified pathway to skin inflammation in systemic sclerosis.
    Kowal-Bielecka O; Distler O; Neidhart M; Künzler P; Rethage J; Nawrath M; Carossino A; Pap T; Müller-Ladner U; Michel BA; Sierakowski S; Matucci-Cerinic M; Gay RE; Gay S
    Arthritis Rheum; 2001 Aug; 44(8):1865-75. PubMed ID: 11508440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.